Genetic deletion or pharmacologic inhibition of the enzyme arachidonate 5-lipoxygenase (Alox5), which generates leukotrienes, suppresses the pro-metastatic activity of neutrophils and consequently decreases cancer metastasis. The gene discussed is ALOX5; the disease is cancer.